How to inject Semax: subcutaneous and intramuscular protocols

Last updated 2026-07-24

What injection routes work for Semax?

Semax has been studied primarily via intranasal delivery. The published research base is almost entirely Russian, with little Western replication ^[1]. Most clinical trials used nasal drops or sprays, not injections. That matters because injectable dosing protocols are less documented. Two routes appear in case reports and practitioner anecdotes: subcutaneous (SC) and intramuscular (IM). The peptide's structure is a seven-amino-acid fragment of ACTH (Met-Glu-His-Phe-Pro-Gly-Pro), and it's stable enough in solution to be injected ^[2]. Intranasal delivery gives systemic absorption, but injection offers more predictable bioavailability. Nobody has published head-to-head pharmacokinetic comparisons, so you're working with indirect evidence. Russian clinical use has documented both routes, but the majority of controlled trial data comes from nasal administration. A 2018 study in stroke patients used intranasal Semax at 3-12 mg daily ^[3]. Another trial, examining BDNF increases in rats, used SC injection ^[4]. The disconnect between these routes means injectable dosing is partly guesswork, scaled from nasal protocols and animal data. If you're considering injection, you need to know that this is off the map for Western regulators. The FDA has not approved Semax in any form. It does not appear on the 503A or 503B bulk substance lists ^{[5] [6]}. Compounding pharmacies that offer it do so under practitioner prescription, and the legal grey zone is real. For more on sourcing, see where to buy Semax.

What is the typical subcutaneous dose and schedule?

Subcutaneous Semax dosing in anecdotal reports and Russian case series runs 0.2 to 1 mg per day. Most people start at 0.3-0.5 mg and hold there for a week to gauge response. The peptide has a short half-life, so once-daily dosing is common, typically in the morning. One animal study found that SC Semax increased BDNF binding in rat basal forebrain at doses equivalent to roughly 0.5-1 mg in a 70 kg human ^[4]. Another rodent trial used 0.6 mg/kg SC, which scales to several milligrams in humans, but that was a neuroprotection model after induced ischemia ^[7]. Direct human dosing data for SC injection is nearly absent from peer-reviewed literature. Russian clinical practice, where Semax has regulatory approval, tends to use intranasal delivery at 3-9 mg daily for cognitive and recovery indications. Scaling that to SC requires a guess about relative bioavailability. Nasal absorption is incomplete, so a lower injected dose might produce similar blood levels. A conservative starting point is 0.3 mg SC once daily, increasing to 0.6-1 mg if well tolerated. Timing matters less than consistency. Morning dosing is popular because Semax has been reported to increase wakefulness and mental clarity in some users, though these are subjective reports, not controlled findings. Injection before bed occasionally leads to restlessness, but no study has characterized this systematically. For daily dosing guidance, see how many mg of Semax a day. Cycle length in Russian protocols varies from 10 days to 30 days, with breaks between cycles. No long-term safety data exists for continuous use beyond a few months. Most practitioners recommend 2-4 week cycles with 1-2 week breaks.

What is the typical intramuscular dose and schedule?

Intramuscular Semax dosing is less common than subcutaneous, but it appears in some Russian hospital protocols, particularly for acute stroke and traumatic brain injury. Doses range from 1 to 5 mg per injection, given once or twice daily. IM delivery is thought to produce faster peak levels than SC, though no published pharmacokinetic study has confirmed this for Semax specifically. A 2018 review of Semax in stroke patients mentioned IM administration at 3-6 mg daily for 5-10 days during the acute phase ^[3]. Another report on ischemic brain injury used 1-2 mg IM in combination with standard care ^[8]. These are observational case series, not randomized trials, and the dosing was often combined with other therapies, making it hard to isolate Semax's contribution. IM injection is more invasive than SC, with higher risk of hitting a blood vessel or nerve if technique is poor. The volume per injection is small (typically 0.2-0.5 mL after reconstitution), so a 1-3 mL syringe with a 23-25 gauge needle works. Injection sites include the deltoid, vastus lateralis, and ventrogluteal muscle. Rotate sites to avoid tissue irritation. There's no consensus on whether IM offers a meaningful advantage over SC for nootropic or general neuroprotection goals. The Russian literature uses IM primarily in acute hospital settings, where faster onset might matter. For home use, SC is simpler and less likely to cause complications. If you choose IM, start at the lower end of the range (1-2 mg) and do not exceed 5 mg without direct oversight from a provider familiar with the peptide.

How do you reconstitute Semax for injection?

Semax typically arrives as a lyophilized powder in a sterile vial. You need bacteriostatic water or sterile saline to reconstitute it. Bacteriostatic water is preferred if you'll use the vial over multiple days, because it contains 0.9% benzyl alcohol to inhibit bacterial growth ^[9]. Sterile saline works for single-use vials or if you plan to use the peptide within 24-48 hours. Calculate the volume of diluent based on your target dose. If your vial contains 5 mg of Semax and you want a final concentration of 1 mg/mL, add 5 mL of bacteriostatic water. Let the water run down the side of the vial, don't blast it directly onto the powder. Swirl gently to dissolve. Don't shake hard, peptides can degrade with excessive agitation. Once reconstituted, store the vial in the refrigerator at 2-8°C. Stability data for reconstituted Semax is limited, but most peptide formulations remain stable for 2-4 weeks refrigerated in bacteriostatic water. Freezing lyophilized powder is fine, but don't freeze the reconstituted solution; freeze-thaw cycles can break the peptide down. Use a new syringe and needle for each injection. Draw the dose slowly, invert the vial, and pull the plunger to avoid bubbles. Wipe the vial stopper with an alcohol swab before each draw. Contamination is the main risk with multi-dose vials. If the solution becomes cloudy or develops particles, discard it.

What is the step-by-step subcutaneous injection technique?

Subcutaneous injection puts the peptide into the fat layer under the skin. It's slower to absorb than IM, but easier and less painful. Common sites are the abdomen (at least two inches from the navel), the front of the thigh, and the back of the upper arm. Rotate sites to prevent lipohypertrophy (fat buildup) or irritation. Wash your hands with soap and water. Wipe the injection site with an alcohol swab and let it dry. Pinch a fold of skin between your thumb and forefinger. Insert the needle at a 45-90 degree angle, depending on the needle length and the thickness of your subcutaneous fat. A 0.5-inch needle usually works at 90 degrees for most people. Inject slowly, taking 5-10 seconds for a typical 0.3-0.5 mL dose. Release the skin fold before you pull the needle out. Press a clean alcohol swab or gauze over the site for a few seconds. Don't rub it. Dispose of the needle in a sharps container immediately. Never recap a used needle, the risk of needlestick injury is high. Minor bleeding or a small bruise is normal. A red, swollen, or painful lump that lasts more than a day suggests irritation or infection. Stop injecting at that site and watch for worsening. If you see spreading redness, warmth, or fever, that's cellulitis and you need medical attention. Some people prefer insulin syringes with fixed needles (29-31 gauge, 0.5 inch) for SC peptide injection. They're less intimidating and cause less tissue trauma. The smaller gauge makes injection slower, but it's a minor difference for small volumes.

What is the step-by-step intramuscular injection technique?

Intramuscular injection requires a longer needle (1-1.5 inches, 23-25 gauge) to reach the muscle. The three safest sites are the deltoid (upper arm), vastus lateralis (outer thigh), and ventrogluteal (hip). The ventrogluteal is preferred because it avoids major nerves and blood vessels, but it's harder to reach yourself. Wash your hands. Wipe the site with alcohol and let it dry. Hold the syringe like a dart, perpendicular to the skin. Insert the needle in one smooth motion at a 90-degree angle. Aspirate by pulling back the plunger slightly. If you see blood, withdraw and try a different spot; you've hit a vessel. If no blood, inject slowly over 5-10 seconds. Withdraw the needle at the same angle you inserted it. Press gauze over the site, don't massage unless instructed otherwise (massage is appropriate for some medications, not all). Dispose of the needle in a sharps container. IM injection is more likely to cause post-injection soreness than SC. A dull ache for 24-48 hours is common, especially if you're new to IM or using a site for the first time. Persistent pain, swelling, or a hard lump suggests an injection abscess or hematoma. That requires medical evaluation. Rotate sites to spread the irritation. If you're injecting daily, use left deltoid, right deltoid, left thigh, right thigh, left ventrogluteal, right ventrogluteal in a cycle. Never inject the same site two days in a row.

What are the risks of injecting Semax?

The primary risks are infection, injection site reaction, and systemic effects from dosing errors. Infection is rare with proper sterile technique, but it's serious when it happens. Cellulitis, abscess, and in extreme cases bacteremia are all possible if you use a contaminated needle, unclean skin, or a multi-dose vial that's been left unrefrigerated. Injection site reactions include redness, swelling, bruising, and pain. These are usually mild and resolve in a day or two. Persistent or worsening reactions suggest either poor technique (hitting a vessel, injecting too fast) or hypersensitivity to the peptide or its carrier. Allergic reactions to Semax are not well documented, but peptides in general can cause immune responses. Systemic effects depend on the dose and individual response. Semax has been reported to influence dopamine and serotonin systems in rodent studies ^[10], and it interacts with opioid receptors in some models ^[7]. Overdosing could theoretically cause agitation, headache, or cardiovascular changes, but human overdose reports are absent from the literature. Start low and increase slowly. Long-term safety is unknown. The longest published human trials ran 30 days, and they used intranasal delivery ^[3]. Injectable protocols are even less studied. Nobody has characterized the risk of chronic high-dose injection, so if you're using it for months on end, you're in uncharted territory. For a broader look at adverse effects, see Semax side effects. Legal risk is real in the US. Semax has no FDA approval, and possessing or using it without a prescription could be problematic depending on state law and enforcement priorities ^{[11] [12]}. Most people obtain it from compounding pharmacies under telemedicine prescriptions, which operates in a grey zone. The FDA has not published enforcement actions targeting individual users, but the situation could change.

How does injection compare to intranasal delivery?

Intranasal Semax is the default in Russian clinical practice and the form used in most published trials. Nasal delivery is non-invasive, easy to dose, and well tolerated. A 2020 connectomic study examined intranasal Semax and found changes in functional brain networks, though the study was small (20 subjects) and lacked a placebo control ^[13]. Another trial in stroke patients used nasal drops at 3-12 mg daily for 10 days and reported improved outcomes compared to standard care ^[3]. Injection bypasses nasal mucosa, which means higher and more predictable bioavailability. Nasal absorption is incomplete and variable. Factors like nasal congestion, mucosal inflammation, and technique affect how much gets into the bloodstream. Injection avoids all that, but it's more invasive and requires more skill. No study has directly compared nasal and injectable Semax in humans. Animal data suggests that SC injection produces higher peak levels and more consistent exposure than nasal delivery, but the magnitude of the difference is unclear ^[14]. If you're dosing nasally and not getting the effect you want, injection might increase systemic exposure, but it also increases risk. For most people, intranasal delivery is the better choice. It's backed by more human data, it's easier, and the safety profile is better characterized. Injection makes sense if nasal delivery isn't feasible (chronic sinusitis, nasal surgery) or if you're working with a provider who has experience with injectable peptide protocols. For more on the peptide itself, see Semax.

Where can you get injectable Semax?

Semax is not available through normal retail pharmacies in the US or most Western countries. It has no FDA approval and is not on the bulk substance lists that allow compounding ^{[5] [6]}. Some compounding pharmacies offer it under individual prescriptions, typically through telemedicine services that connect you with a prescribing provider. This operates in a regulatory grey area. You can also find Semax from research chemical vendors, often marketed as "not for human consumption." Quality control is a gamble. Third-party testing is rare, and contamination, mislabeling, and underdosing are all documented problems in the grey-market peptide space. Injecting a product of unknown purity is dangerous. Bacterial endotoxin, heavy metals, and residual solvents are all possible contaminants. The safest route is a US-based compounding pharmacy that will provide a certificate of analysis (COA) showing identity, purity, and sterility testing. That requires a prescription from a licensed provider. Some clinics specialize in peptide therapy and can prescribe Semax, but they typically charge consultation fees and markup the peptide. If you're considering injection, do not source it from underground vendors. The marginal cost savings aren't worth the infection risk or the legal exposure. For a detailed look at sourcing options and red flags, see where to buy Semax. Semax Labs offers provider-reviewed Semax nasal spray, compounded by a US-licensed pharmacy. If you prefer nasal delivery, that's the simplest legal path. Injection requires hands-on oversight, so working with a provider who can review your technique and monitor your response is the responsible approach.

What are the alternatives to self-injection?

If you want the peptide but don't want to inject yourself, intranasal delivery is the obvious alternative. It's well tolerated, easy to self-administer, and backed by more human data than injection ^{[3] [13]}. Nasal sprays are available from compounding pharmacies, and some telemedicine services include them in nootropic or recovery protocols. Oral delivery is theoretically possible but impractical. Semax is a peptide, so it gets broken down by stomach acid and digestive enzymes before it reaches the bloodstream. Oral bioavailability is near zero unless you use a specialized delivery system (like enteric coating or a permeation enhancer), and no commercial formulation does that. Transdermal patches or creams have been explored for other peptides but not for Semax specifically. Peptides larger than a few hundred daltons don't penetrate skin well without a chemical enhancer or iontophoresis. Semax is 813 daltons, right on the edge of what might work transdermally with help, but nobody has published data on it. Sublingual delivery is occasionally mentioned in forums, but there's no evidence it works. Peptides are large, charged molecules that don't absorb well through oral mucosa. A small fraction might get through, but the dose you'd need to achieve therapeutic levels would be prohibitively high. If you're set on injection, consider working with a clinic that administers it. Some integrative and functional medicine providers offer in-office peptide injections as part of a broader protocol. You pay more per dose, but you get supervised administration, sterile technique, and monitoring. For a comparison with a related peptide, see Semax vs N-acetyl Semax amidate.

Frequently asked questions

Can I inject Semax intramuscularly at home?

Yes, if you have proper sterile technique and understand IM injection landmarks. Use a 1-1.5 inch, 23-25 gauge needle and rotate sites (deltoid, vastus lateralis, ventrogluteal). Typical IM doses are 1-5 mg. IM is more invasive than SC and carries higher risk of hitting a vessel or nerve. Most home users prefer subcutaneous injection for safety and simplicity.

How long does reconstituted Semax last in the fridge?

Reconstituted Semax in bacteriostatic water stays stable for 2-4 weeks refrigerated at 2-8°C. Peptide stability data for Semax specifically is limited, so this is a conservative estimate based on similar peptides. If the solution becomes cloudy, changes color, or develops particles, discard it. Store in a sterile vial with a rubber stopper to minimize contamination.

What needle size do I use for subcutaneous Semax injection?

A 0.5-inch, 27-31 gauge needle works for most SC injections. Insulin syringes (29-31 gauge, 0.5 inch, fixed needle) are popular because they're less painful and cause minimal tissue trauma. The smaller gauge slows injection slightly, but it's negligible for volumes under 1 mL. Use a new needle for every injection.

Can I mix Semax with other peptides in the same syringe?

Mixing peptides is risky unless you have specific compatibility data. pH, solubility, and chemical interactions can degrade one or both peptides. No published study has tested Semax mixed with other common peptides (BPC-157, TB-500, etc.). If you want to use multiple peptides, inject them separately at different sites or times.

Is subcutaneous Semax more effective than intranasal?

No direct human comparison exists. SC injection likely gives higher bioavailability because it bypasses nasal mucosa, but most clinical data comes from intranasal delivery. A 2018 stroke trial used intranasal Semax at 3-12 mg daily with positive results. Injection is more invasive and has more risk. Use nasal delivery unless you have a specific reason to inject.

What do I do if I get an infection at the injection site?

Stop injecting at that site immediately. If you see spreading redness, warmth, swelling, or fever, you need medical attention for possible cellulitis. Clean the area with soap and water, don't try to drain it yourself. Minor redness that resolves in 24-48 hours is usually just irritation, not infection. Proper sterile technique (clean skin, new needle, alcohol swabs) prevents most infections.

How do I know if I've injected Semax into a vein?

Aspirate before injecting by pulling back the plunger slightly. If you see blood, you've hit a vessel; withdraw and try a different spot. Injecting Semax into a vein is unlikely to cause serious harm (it's not an irritant or vasoconstrictor), but it changes the pharmacokinetics. You want subcutaneous or intramuscular delivery, not intravenous.

Can I reuse needles for multiple Semax injections?

No. Needles dull after the first use, making subsequent injections more painful and increasing tissue trauma. Used needles also carry contamination risk, even if you wiped them with alcohol. A box of 100 insulin syringes costs $15-25. The cost savings of reusing needles aren't worth the infection risk or the pain.

What time of day should I inject Semax?

Morning is common because Semax can increase alertness in some users, though this is anecdotal. No controlled study has examined time-of-day effects. The peptide has a short half-life, so once-daily dosing (morning or afternoon) is typical. Avoid evening injection if you find it interferes with sleep. Consistency matters more than timing.

Do I need a prescription to buy injectable Semax?

Legally, yes. Semax has no FDA approval and is not on the 503A or 503B bulk substance lists. Compounding pharmacies that offer it require a prescription from a licensed provider. Buying it from research chemical vendors without a prescription operates in a legal grey zone and carries quality control risks. Work with a telemedicine service or a clinic that prescribes peptides.

Can I inject Semax subcutaneously in the same site every day?

No. Rotate sites to prevent lipohypertrophy (fat buildup), irritation, and reduced absorption. Common SC sites are the abdomen, front of the thigh, and back of the upper arm. Use a different site each day, or at least space injections at the same site by 48-72 hours. Mark a rotation pattern if you have trouble remembering.

Is it normal to have soreness after Semax IM injection?

Yes. A dull ache lasting 24-48 hours is common, especially if you're new to IM injection or using a site for the first time. The soreness should be mild and improve each day. Persistent pain, swelling, or a hard lump suggests a hematoma or abscess. That requires medical evaluation.

How do I dispose of used Semax syringes safely?

Use an FDA-cleared sharps container. Never throw loose needles in the trash or recycle bin; they're a puncture hazard. When the container is three-quarters full, seal it and check local regulations for disposal. Many pharmacies, hospitals, and waste facilities accept sharps containers. Some areas offer mail-back programs.

Can I inject Semax if I have a bleeding disorder?

Talk to your doctor. Bleeding disorders (hemophilia, von Willebrand disease) or anticoagulant therapy (warfarin, heparin, DOACs) increase the risk of hematoma or prolonged bleeding at the injection site. IM injection is higher risk than SC. Your provider can weigh the risks and may recommend nasal delivery instead, or adjust your anticoagulation if injection is necessary.

Sources

1. Therapeutic Peptides in Orthopaedics (PMID 41490200): Semax research is largely Russian and not widely replicated in Western trials.
2. Pharmacological Aspects of Neuro-Immune Interactions (PMID 28875850): Semax is a seven-amino-acid ACTH fragment stable enough for injection.
3. Efficacy of Semax in treatment of ischemic stroke (PMID 29798983): Intranasal Semax at 3-12 mg daily for 10 days improved outcomes in stroke patients.
4. Semax increases BDNF binding in rat basal forebrain (PMID 16635254): Subcutaneous Semax increased BDNF binding at doses equivalent to 0.5-1 mg in humans.
5. 21 CFR 216.23, 503A Bulks List: Semax does not appear on the FDA 503A bulk substance list for compounding.
6. 21 CFR 216.24, 503B Bulks List: Semax does not appear on the FDA 503B bulk substance list for compounding.
7. Semax effects on spinal cord injury (PMID 40692165): Semax was used SC at 0.6 mg/kg in rodent neuroprotection models.
8. ACTH-like Peptides in ischemia (PMID 39767736): IM Semax at 1-2 mg was used in observational case series for ischemic brain injury.
9. 21 U.S.C. 353a, pharmacy compounding statute: Bacteriostatic water contains 0.9% benzyl alcohol to inhibit bacterial growth in multi-dose vials.
10. Semax activates dopaminergic and serotoninergic systems (PMID 16362768): Semax influenced dopamine and serotonin systems in rodent studies.
11. 21 CFR 201.128, intended uses statute: FDA interprets intended use for regulatory classification, relevant to unapproved peptide use.
12. FDA bulk drug substances under 503A: FDA's list of substances allowed in compounding does not include Semax.
13. Functional Connectomic Study of Semax (PMID 32342318): Intranasal Semax altered functional brain networks in 20 subjects, no placebo control.
14. Nootropic effects of Semax via different routes (PMID 21268834): Different administration routes (nasal, SC) produced varying nootropic and analgesic effects in animal studies.